Skip to main content

How can we help you?

  • Deal or case news
  • 15-12-2017

VIB is a life-sciences research institute performing basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial applications. Over the past few years, NautaDutilh has assisted VIB with the incorporation of several spin-offs.

The most recent project we worked on with VIB was the incorporation of Aelin Therapeutics, a privately held Belgian biotherapeutics company which has secured a EUR 27 million investment to pioneer a novel development to create a completely new class of antibiotics and first-in-class therapeutics for use against high-value undruggable human targets.

The technology, known as Pept-ins™, harnesses the power of protein aggregation to specifically induce functional knockdown of a target protein.

NautaDutilh's team, led by Elke Janssens and Florence Verhoestraete, assisted VIB.

View VIB's official press release here.

Cookie notice

Our website only uses cookies when you play video content. Video content is streamed from Vimeo. Our website does not use tracking cookies and/or third party cookies when you do not play video content. Please read the privacy/cookie policy for more information.